References
- Polli G, Bacci P, De Luca O, Ciabatti PG, Fioretti C. Nasal provocation test in the diagnosis of vasomotor rhinitis. Acta Otorhinolaryngol Ital 1983; 3: 19–29
- Bousquet C. World Health Organization Initiative Allergic Rhinitis and its Impact on Asthma (ARIA). World Health Organization, Geneva 2001
- Philip G, Togias AG. Nonallergic rhinitis. Pathophysiology and models for study. Eur Arch Otorhinolaryngol 1995; 252(Suppl 1)S27–S32
- Blom HM, Godthelp T, Fokkens WJ, Klein Jan A, Holm AF, Vroom TM, et al. Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol 1995;252(Suppl 1):S33–S39.
- Blom HM, Severijnen LA, Van Rijswijk JB, Mulder PG, Van Wijk RG, Fokkens WJ. The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998; 28: 1351–8
- Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol 1998; 12: 65–72
- Szallasi A, Blumberg PM. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res 1990; 524: 106–11
- Lacroix JS, Kurt AM, Pochon N, Bretton C, Lundberg JM, Deshusses J. Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa. Eur Arch Otorhinolaryngol 1995; 252: 465–8
- Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A. Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin. Laryngorhinootologie 1995; 74: 289–93
- Riechelmann H, Davris S, Bader D. Treatment of perennial non-allergic rhinopathy with capsaicin. HNO 1993; 41: 475–9
- Marabini S, Ciabatti PG, Polli G, Fusco BM, Geppetti P. Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol 1991; 248: 191–4
- Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997; 27: 796–801
- Lacroix JS, Buvelot JM, Polla BS, Lundberg JM. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991; 21: 595–600
- Kitajiri M, Kubo N, Ikeda H, Sato K, Kumazawa T. Effects of topical capsaicin on autonomic nerves in experimentally-induced nasal hypersensitivity. An immunocytochemical study. Acta Otolaryngol Suppl 1993; 500: 88–91
- Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy 2003; 58: 754–61
- Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994; 77: 135–40
- Caterina MJ. Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R64–76
- Geppetti P, Materazzi S, Nicoletti P. The transient receptor potential vanilloid 1: role in airway inflammation and disease. Eur J Pharmacol 2006; 533: 207–14
- Movahed P, Jönsson BA, Birnir B, Wingstrand JA, Jørgensen TD, Ermund A, et al. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem 2005;280:38496–504.
- Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 2007;104:13519–24.